Bernard Roubert

3.0k total citations · 4 hit papers
19 papers, 2.1k citations indexed

About

Bernard Roubert is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bernard Roubert has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Genetics and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bernard Roubert's work include Erythropoietin and Anemia Treatment (16 papers), Iron Metabolism and Disorders (14 papers) and Hemoglobinopathies and Related Disorders (8 papers). Bernard Roubert is often cited by papers focused on Erythropoietin and Anemia Treatment (16 papers), Iron Metabolism and Disorders (14 papers) and Hemoglobinopathies and Related Disorders (8 papers). Bernard Roubert collaborates with scholars based in Switzerland, Germany and Netherlands. Bernard Roubert's co-authors include Piotr Ponikowski, Dirk J. van Veldhuisen, Stefan D. Anker, Gerasimos Filippatos, Josep Comín‐Colet, Claudio Mori, Frank Ruschitzka, Georg Ertl, Luigi Tavazzi and Mareev VIu and has published in prestigious journals such as Circulation, Blood and European Heart Journal.

In The Last Decade

Bernard Roubert

19 papers receiving 2.0k citations

Hit Papers

Beneficial effects of long-term intravenous iron therapy ... 2014 2026 2018 2022 2014 2017 2017 2023 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Roubert Switzerland 13 1.5k 975 623 185 181 19 2.1k
Joanna Niegowska Poland 6 994 0.7× 759 0.8× 416 0.7× 138 0.7× 179 1.0× 17 1.6k
Shoshana Steinbruch Israel 8 1.2k 0.8× 548 0.6× 362 0.6× 435 2.4× 111 0.6× 9 1.5k
S. D. Anker Germany 9 545 0.4× 738 0.8× 212 0.3× 73 0.4× 155 0.9× 17 1.2k
Bella Koifman Israel 12 468 0.3× 463 0.5× 108 0.2× 181 1.0× 87 0.5× 15 907
Luís Beck da Silva Neto Brazil 15 218 0.1× 676 0.7× 73 0.1× 63 0.3× 189 1.0× 52 964
Maros Elsik Australia 13 318 0.2× 891 0.9× 107 0.2× 229 1.2× 122 0.7× 22 1.4k
Pieter Martens Belgium 19 193 0.1× 734 0.8× 58 0.1× 133 0.7× 226 1.2× 72 1.1k
Szu-Chun Hung Taiwan 18 221 0.1× 205 0.2× 110 0.2× 530 2.9× 147 0.8× 30 1.3k
Petra Nijst Belgium 22 188 0.1× 1.2k 1.2× 59 0.1× 335 1.8× 625 3.5× 64 1.7k
J. Silberberg Australia 16 216 0.1× 704 0.7× 67 0.1× 587 3.2× 134 0.7× 31 1.5k

Countries citing papers authored by Bernard Roubert

Since Specialization
Citations

This map shows the geographic impact of Bernard Roubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Roubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Roubert more than expected).

Fields of papers citing papers by Bernard Roubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Roubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Roubert. The network helps show where Bernard Roubert may publish in the future.

Co-authorship network of co-authors of Bernard Roubert

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Roubert. A scholar is included among the top collaborators of Bernard Roubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Roubert. Bernard Roubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ponikowski, Piotr, Robert J. Mentz, Adrian F. Hernandez, et al.. (2023). Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. European Heart Journal. 44(48). 5077–5091. 67 indexed citations breakdown →
3.
Khan, Muhammad Shahzeb, Stefan D. Anker, Tim Friede, et al.. (2022). Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency. Journal of Cardiac Failure. 29(5). 760–770. 18 indexed citations
4.
Ding, Yanhua, Xiaoxue Zhu, Xiaojiao Li, et al.. (2020). Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia. Clinical Therapeutics. 42(2). 276–285. 14 indexed citations
5.
Butler, Javed, Muhammad Shahzeb Khan, Claudio Mori, et al.. (2020). Minimal Clinically Important Difference in Quality of Life Scores for Patients with Heart Failure and Reduced Ejection Fraction. European Journal of Heart Failure. 22(6). 999–1005. 75 indexed citations
6.
Richard, Frank, et al.. (2019). Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers. American Journal of Hematology. 95(1). 68–77. 58 indexed citations
7.
Veldhuisen, Dirk J. van, Piotr Ponikowski, Peter van der Meer, et al.. (2017). Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. Circulation. 136(15). 1374–1383. 302 indexed citations breakdown →
8.
Anker, Stefan D., Bridget‐Anne Kirwan, Dirk J. van Veldhuisen, et al.. (2017). Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis. European Journal of Heart Failure. 20(1). 125–133. 291 indexed citations breakdown →
9.
Trenkwalder, Claudia, Juliane Winkelmann, Wolfgang H. Oertel, et al.. (2017). Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial. Movement Disorders. 32(10). 1478–1482. 51 indexed citations
11.
Anker, Stefan D., Michael Böehm, Josep Comín‐Colet, et al.. (2017). 251Cardiovascular hospitalisation and death by subgroup in iron-deficient patients with heart failure treated with intravenous ferric carboxymaltose: an individual patient meta-analysis. European Heart Journal. 38(suppl_1). 1 indexed citations
12.
Breymann, Christian, Nils Milman, Anna Mezzacasa, Bernard Roubert, & Joachim W. Dudenhausen. (2016). Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). Journal of Perinatal Medicine. 45(4). 443–453. 86 indexed citations
13.
Macdougall, Iain C., Andreas Böck, Fernando Carrera, et al.. (2015). FO016HEPCIDIN RESPONSE TO IRON THERAPY IN PATIENTS WITH NON-DIALYSIS CKD: AN ANALYSIS OF THE FIND-CKD TRIAL. Nephrology Dialysis Transplantation. 30(suppl_3). iii8–iii9. 1 indexed citations
14.
Macdougall, Iain C., A. Böck, Fernando Carrera, et al.. (2014). FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrology Dialysis Transplantation. 29(11). 2075–2084. 207 indexed citations
15.
Hedenus, Michael, et al.. (2014). Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Medical Oncology. 31(12). 302–302. 31 indexed citations
17.
Ponikowski, Piotr, Dirk J. van Veldhuisen, Josep Comín‐Colet, et al.. (2014). Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal. 36(11). 657–668. 821 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026